2024 Intra cellular therapies top shareholders

Intra cellular therapies top shareholders

Author: xqmr

August undefined, 2024

WebJan 9, 2024 · Events and Presentations Intra-Cellular Therapies Inc. Events. 22nd Annual Needham Virtual Healthcare Conference. April 18, 2024 at 11:45 AM EDT. Listen to … WebNov 5, 2024 · Intra-Cellular Therapies, Inc. ( NASDAQ:ITCI ) shareholders might be concerned after seeing the share price drop 15% in...

Companies Like Intra-Cellular Therapies (NASDAQ:ITCI) Are In A …

WebJun 15, 2024 · Has Intra-Cellular Therapies, Inc. Been A Good Investment? Boasting a total shareholder return of 111% over three years, Intra-Cellular Therapies, Inc. has … Web51 rows · The Investor Relations website contains information about Intra-Cellular Therapies Inc.'s business for stockholders, potential investors, and financial analysts. sprint cell phone service offers

Events and Presentations Intra-Cellular Therapies Inc.

WebApr 6, 2024 · As of April 06, 2024, 4:00 PM CST, Intra-Cellular Therapies Inc’s stock price was $59.30. Intra-Cellular Therapies Inc is up 4.94% from its previous closing price of $56.51. During the last market session, Intra-Cellular Therapies Inc’s stock traded between $55.26 and $56.92. Currently, there are 94.76 million shares of Intra-Cellular ... WebApr 11, 2024 · NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the … WebApr 10, 2024 · ITCI Stock Overview. Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that address medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms in the central nervous system … sprint cell phone tethering

The three-year returns have been fantastic for Intra-Cellular Therapies ...

WebDec 14, 2024 · It's nice to see that Intra-Cellular Therapies shareholders have received a total shareholder return of 44% over the last year. That gain is better than the annual … WebIntra-Cellular Therapies annual and quarterly earnings per share history from 2013 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants. sherborne directionsWebApr 6, 2024 · Intra-Cellular Therapies last released its quarterly earnings results on March 1st, 2024. The biopharmaceutical company reported ($0.45) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.62) by $0.17. The business earned $87.87 million during the quarter, compared to analyst estimates of $86.97 million. sprint cell phone time wrong

"WebSep 11, 2024 · NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company, today announced the … " - Intra cellular therapies top shareholders

Intra cellular therapies top shareholders

Targeting advanced prostate cancer with STEAP1 chimeric antigen ...

WebApr 7, 2024 · Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel ... large-cap names account for the largest 70% of U ... They rarely distribute dividends to shareholders, ... WebTel +1 248 290 5400. Fax +1 248 290 5401. Email [email protected]. Purpose: Tardive dyskinesia (TD) is a hyperkinetic movement disorder in which patients experience abnormal involuntary movements that can have profound negative impacts on physical, cognitive, and psychosocial functioning. Use of measures to assess the …

Did you know?

WebApr 14, 2024 · Finance. Industry. Market WebJan 27, 2024 · The Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) share price is down a rather concerning 33% in the last month. But...

WebMar 14, 2024 · A look at the shareholders of Intra-Cellular Therapies, Inc. ... Meanwhile, the second and third largest shareholders, hold 8.8% and 7.3%, of the shares … WebIntracerebral hemorrhage in ICU: is it worth treating?

Web/ Intra-Cellular Therapies, Inc. Intra-Cellular Therapies, Inc. Website. Get a D&B Hoovers Free Trial. ... Shareholders Equity; All financial statement data is in millions except per share data Source: ... D&B Hoovers TM Wins 3 Best Of Awards from TrustRadius! Award-Winning Sales Intel. WebApr 27, 2024 · Sharon Mates has been the CEO of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) since 2013. This report will, first...

Web2 days ago · Gubra A/S is a Denmark-based biotechnology company specialized in high-end pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases. The Companyâ€™s operations are anchored around its advanced technology platforms and utilization of automation, robotization and digitalization, including machine ...

WebDec 14, 2024 · Intra-Cellular Therapies, Inc. ( NASDAQ:ITCI ) shareholders might be concerned after seeing the share price drop 11% in... sprint cell phone tower finderWebMar 31, 2024 · Intra-Cellular Therapies, Inc. is a biopharmaceutical company. The Company is focused on the discovery, clinical development and commercialization of … sprint cell phone tethering freeWebApr 11, 2024 · These include dual antigen-targeted (e.g., PSMA and STEAP1) CAR T cell therapies or multimodal strategies combining CAR T cell therapies with ADCs, T-BsAbs, or other treatments that potently ... sherborne dining setWebFeb 2, 2024 · The company's largest shareholder is FMR LLC, with ownership of 12%. Wasatch Advisors Inc. is the second largest shareholder owning 9.0% of common … sprint cell phone towers downWeb1 day ago · April 13, 2024. Pfizer Inc. (NYSE: PFE) announced today that its shareholders and the general public are invited to access its virtual-only 2024 Annual Meeting of Shareholders at 9:00 a.m. EDT on ... sprint cell phone tower map sprint cell phones for seniors elderlyWebIntra Cellular Therapies (NASDAQ: ITCI) is owned by 87.14% institutional shareholders, 25.82% Intra Cellular Therapies insiders, and 0.00% retail investors. Christopher D. … sherborne doctors